Navigation Links
STaK-Chex Plus Retics 5-Part Differential Control

ProductsSTaK-Chex Plus Retics 5-Part Differential Control
Company Streck
Item STaK-Chex Plus Retics 5-Part Differential Control
Features 
Description STaK-Chex Plus Retics is a 5-part differential control that controls all parameters, including reticulocytes, for the Coulter GENS, STKS, LH 750/LH 755, MAXM and HmX instruments. The assay contains automated and manual reticulocyte values for all three levels. White blood cell types and reticulocyte percentages vary and are within clinically significant ranges. This unique product has 14-day open-vial stability and 105-day closed-vial stability, which can be used for three months. The 4.5ml pierceable cap vial is barcoded and compatible with all instruments. Assay disk available.
Info Streck
Customer Service: (800) 228-6090
Web site: http://www.streck.com/default.asp

Related medicine products :

1. STaK-Chex White Cell Differential Control
2. Para 12 Plus Retics 5-Part Differential Control
3. CBC with Platelet Count & Automated Differential
4. Manual Differential
5. Para 5X Whole Blood Hematology Control, Five-part Differential
6. Para 12 Extend Whole Blood Hematology Control, Three-part Differential
7. Para 12 Whole Blood Hematology Control, Three-part Differential
8. Endoalpha Centralized O.R. Control System
9. Cruise Control
10. US Autoflow Single Chamber Stackable Water-Jacketed CO2 Inc.w/ Humidity Display and Control
11. Fluid Control 2203
... Integra Epilepsy Flex Connector represents ... design of epilepsy electrodes. This ... tunneling and attachment to the ... Connector is provided with a ...
...
... Electrodes provide you with an alternative method ... same proven design as Ad-Techs Spencer Probe ... using an introducing needle instead of a ... diameter, 3 to 6 platinum recording contacts, ...
... Ad-Techs Spencer Probe Depth Electrodes offers you ... one-piece main body structure which uses a ... actually become more flexible as it reaches ... electrodes feature a small 1.0 mm diameter ...
Medicine Products:
(Date:6/28/2017)... , ... June 28, 2017 , ... ... management and financial planning assistance to clients in southern Montana, is announcing a ... by Zoo Montana. , The outreach programs offered by Zoo Montana provide students ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... DrugDev ... study is whether they can trust the sponsor to pay them correctly and on ... sponsors and CROs establish payment strategies that encourage sites to work on their studies. ...
(Date:6/27/2017)... ... 2017 , ... The Congressional Budget Office (CBO) projects that the Better Care ... Protection and Affordable Care Act (ACA), would result in 22 million Americans losing their ... , More than 20 million Americans have gained health insurance under the ACA, and ...
(Date:6/27/2017)... ... , ... A January 18th article on medGadget reports that the ... the year 2024 according to a new report. The article also notes that the ... Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center says that it ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... HORSHAM, Pa. , June 19, 2017  Researchers ... announced today that they will host a live, complimentary ... Perspectives from the benchtop to the real world" on ... PM EDT. This webinar will feature ... a rare look into the manipulation techniques abusers use ...
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: